No Data
No Data
Sign post---TTG unmanned payment is used for “Akachanhonpo” in hospitals
Signpost <3996> announced on the 23rd that the TTG (TOUCH TO GO) unmanned payment system has been adopted at the “Akachanhonpo Chibune Hospital Unmanned Payment Shop.” TTG was established by JR East Startup and Signpost. The “Akachanhonpo Chibune Hospital Unmanned Payment Shop” is located in Chibune Hospital in Osaka City, Osaka Prefecture.
Sign Post--- Start providing “DX Accompanying Support Service”
Signpost <3996> announced on the 23rd that it will begin providing a “DX companion support service” to support the digital transformation (DX) of small and medium-sized enterprises. As the first initiative of the DX Accompanying Support Service, the Daishi Hokuetsu Bank will support the preparation of the DX Declaration when developing the “DX Declaration Formulation Support Service,” which will begin handling on 4/24. DX companion support services are IT skills, project management capabilities, and regional funds, which are the company's strengths
Taisei Corporation, Toa Road Industries, etc. (Part 1)
<1801>Taisei Corporation Mizuho Bank, Ltd. Stock Ownership Ratio 5.35% → 4.33% Reporting Obligation Date 2024/04/15 <1882>Toa Road Industries Co., Ltd. Sumitomo Mitsui DS Asset Management Co., Ltd. Stock Ownership Ratio -% → 5.09% Reporting Obligation Date 2024/04/15 <1926>Light Industries, Ltd. Sumitomo Mitsui DS Asset Management Co., Ltd. Stock Ownership Ratio 7.10% → 6.3
Sign post --- 4th “ORBIS Smart Stand” store introducing the unmanned payment system “TTG-SENSE” opens
Sign Post <3996> announced on the 15th that the unmanned payment system “TTG-SENSE,” which develops and sells TOUCH TO GO (TTG) established by the company and JR East Startup, has been introduced to the unmanned cosmetics sales store “ORBIS Smart Stand AEON MALL Mito Uchihara Store.” “ORBIS Smart Stand” opened its first store in Granduo Tachikawa in 2023/5 as an unmanned cosmetics store. Then 2024
Signpost --- Sales increased by 2 digits for the fiscal year ended February '24, profits at each stage became profitable, and the consulting business performed well
Signpost <3996> announced financial results for the fiscal year ending 2024/2 on the 12th. Sales increased 13.8% from the previous fiscal year to 2,929 billion yen, operating income was 101 million yen (loss of 110 million yen in the previous fiscal year), ordinary profit was 94 million yen (loss 119 million yen), and net income was 128 million yen (loss of 132 million yen). Sales in the consulting business increased 14.4% from the same period last year to 2,821 billion yen, and segment profit increased 26.6% to 494 million yen. IT department
Astellas Pharmaceuticals, 24/3 revised downward operating profit 13 billion yen ← 83 billion yen
Astellas Pharmaceuticals <4503> announced revisions to its earnings forecast for the fiscal year ending 2024/3. Operating profit was revised downward from 83 billion yen to 13 billion yen. As a result of reviewing the asset value of the gene therapy program AT808, which is undergoing research and development for Friedreich ataxia patients, impairment losses of approximately 40 billion yen of intangible assets related to AT808 will be recorded as other expenses. [Positive Evaluation] <8233>Takashimaya Full Year | <6432>Takeuchi Production
No Data